Senior Director, Global Lung Cancer Life Cycle Management Lead
Regeneron Pharmaceuticals
About this role
The Senior Director, Global Lung Cancer Life Cycle Management Lead at Regeneron is responsible for developing and leading strategies to maximize the value of in-line oncology products in the Lung Cancer market. The role involves collaboration across global and cross-functional teams to support portfolio growth and market positioning.
Skills
About Regeneron Pharmaceuticals
regeneron.comDiscover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Recent company news
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Capital Research Global Investors Raises Stake in Regeneron Pharmaceuticals, Inc. $REGN
7 hours ago
About Regeneron Pharmaceuticals
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Salary
$216k – $360k
per year
More jobs at Regeneron Pharmaceuticals
Similar Jobs
Brand Manager – Oncology Lung Cancer (m/w/d)
AstraZeneca
Franchise Lead for Oncology Lung Cancer products
AstraZeneca
Oncology Franchise Head, Lung Cancer (Alliance), International
AstraZeneca
Global Marketing Director, Oncology
Amgen
Medical Affairs Manager Oncology (Lung Cancer) (m/w/d)
AstraZeneca
Oncology Franchise Head, Lung Cancer (Alliance), International
AstraZeneca